BREAST CANCER SELECTIVE THERAPEUTIC DEVELOPMENT: LEAD OPTIMIZATION OF A SMALL-MOLECULE INHIBITOR OF THE BREAST CANCER SELECTIVE HUB PROTEIN CAPCNA
$973,480FY2019Defense Health AgencyDOD
Beckman Research Institute Of The City Of Hope
Beckman Research Institute Of The City Of Hope